Expert hematologist Stephen Oh, MD, PhD, provides an overview of myelofibrosis, and discusses how new data from ASH 2022 affect the treatment landscape.
EP. 1: Myelofibrosis Types and Presentations
Stephen Oh, MD, PhD, explains the different types of myelofibrosis and describes the signs and symptoms.
EP. 2: Molecular Targets and Transplant Considerations in Myelofibrosis
An expert hematologist discusses important molecular targets in myelofibrosis, and when to consider transplant.
EP. 3: Treatment Options for Patients with Myelofibrosis: Pacritinib, Fedratinib, and Ruxolitinib
Stephen Oh, MD, PhD, gives a comprehensive review of the available treatment options for myelofibrosis.
EP. 4: A New Option Being Explored for Myelofibrosis
An overview of momelotinib, which was recently submitted for FDA approval, and how myelofibrosis treatments affect quality of life.
EP. 5: Approaching Treatment Selection and Sequencing in Myelofibrosis
Stephen Oh, MD, PhD, describes the factors that influence treatment selection in myelofibrosis, and then reviews sequencing strategies.
EP. 6: Unmet Needs and Promising New Therapies in Myelofibrosis
Expert hematologist, Stephen Oh, MD, PhD, talks about unmet needs and promising new therapies in myelofibrosis.
2 Clarke Drive Cranbury, NJ 08512